Alrubicin 150 mg Injection is a chemotherapy medication used to treat various types of Cancer, including blood, breast, stomach, lung, ovarian, and soft tissue cancers. It contains Epirubicin (150 mg), an anthracycline antineoplastic agent that works by interfering with the DNA of cancer cells, preventing their growth and multiplication.
Manufactured by Alkem Laboratories Ltd, a qualified medical professional slowly administers this intravenous Cancer medication. It is commonly used alone or in combination with other oncology drug therapies.
The dosage and frequency depend on the type of cancer, patient response, and medical condition. The administration process usually takes place in a hospital or specialized treatment center under the close supervision of healthcare experts to monitor potential side effects and ensure safe delivery.
Alrubicin Injection must be stored in a refrigerator (2 - 8°C) and never frozen. Proper storage ensures its effectiveness and safety during treatment. The medication should be handled carefully, following strict storage guidelines to maintain its stability and therapeutic potency. Patients should carefully follow their doctor's instructions to achieve the best possible treatment outcomes while minimizing risks.
Alrubicin 150 Injection is an effective chemotherapy medication that helps manage Cancer by targeting cancerous cells and preventing their proliferation. It works by interfering with the DNA replication process of these cells, ultimately inhibiting their ability to divide and spread.
This helps slow down tumor growth and improve treatment outcomes, making it a crucial component in cancer management.
Key benefits of Alrubicin include:
Alrubicin 150 Injection is a prescription medication that should only be administered by a healthcare professional. General guidelines include:
Alrubicin 150 mg Injection has various strengths and substitutes. Your doctor may adjust your dosage based on your specific condition and response to treatment.
Available strengths include:
| $36.75/ Injection | |
| $121.00/ Injection |
Alrubicin 150 Injection is generally safe when taken as prescribed. However, some patients may experience mild to moderate side effects. Common side effects include:
Seek medical attention if side effects persist or worsen.
Liver disease
Patients with liver disorders should use Alrubicin Injection cautiously, as dose adjustments may be required to prevent complications and ensure treatment efficacy.
Kidney impairment
Individuals with kidney issues need close monitoring during treatment to avoid potential toxicity and ensure proper kidney function is maintained.
Pregnant and breastfeeding women
Not recommended due to potential harm to the fetus or infant. Consult a doctor before use to assess risks and explore alternative treatment options.
Avoid
Alcohol and driving, such as Alrubicin, may cause dizziness, fatigue, or weakness, which could impair coordination and alertness, increasing the risk of accidents.
No, Alrubicin 150 Injection is specifically used for certain types of Cancer, such as breast, stomach, lung, and blood cancers. Your doctor will determine if it is suitable for your condition.
Yes, the injection can interact with several medications, including other chemotherapy agents, antibiotics, heart medications, and immunosuppressants. Always provide your doctor with a complete list of all medications you're taking to prevent potentially dangerous interactions.
Alrubicin Injection requires refrigeration at 2-8°C (36-46°F). Never freeze the medication or expose it to direct sunlight. Keep it in its original container and away from children. Discard any unused portion according to medical guidelines.
Yes, Alrubicin 150 mg injection may cause cardiotoxicity, particularly in patients with existing heart conditions or previous radiation therapy. Regular cardiac monitoring, including echocardiograms, is essential during treatment. Report any chest pain, irregular heartbeat, or shortness of breath immediately.
Yes, temporary hair loss is a common side effect of Alrubicin Injection due to its impact on rapidly dividing cells, including hair follicles. However, hair usually begins to regrow after treatment completion, though texture and color changes may occur.